Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer - Authors' reply

Bjørn H Grønberg, Seppo Wang Langer, Jan Nyman, Tarje Onsøien Halvorsen

Original languageEnglish
JournalThe Lancet Oncology
Volume22
Issue number6
Pages (from-to)e222
ISSN1470-2045
DOIs
Publication statusPublished - Jun 2021

Keywords

  • Chemoradiotherapy/adverse effects
  • Humans
  • Lung Neoplasms/drug therapy
  • Small Cell Lung Carcinoma/drug therapy

Cite this